Skip to content

URMC Response to CrowdStrike Software Issue

Some patient care sites and URMC offices have been affected by the CrowdStrike software issue. Emergency and inpatient care are continuing without interruption. 

Patients: click here for more information. Faculty/Staff: click here for information.

Eran Tallis, M.D.

Eran Tallis, M.D.

Pediatrics , Pediatric Genetics

No ratings currently available, see text in Ratings section below for explanation.

UR Medicine Faculty The University of Rochester Medical Faculty Group (URMFG) consists of over 900 specialist and primary care providers spanning 19 departments. URMFG is certified by the National Committee for Quality Assurance.
Accountable Health Partner Accountable Health Partners (AHP) is a network of over 2,000 community and UR medical faculty and a dozen leading hospitals throughout the region. AHP offers a full range of care.
Accepting New Patients



Metabolic Genetics (Adult & Pediatric) - Rochester

Ambulatory Care Center at Strong Memorial Hospital
601 Elmwood Avenue, 1st Floor
Rochester, NY 14626

Pluta Cancer Center - Henrietta

Red Creek (Calkins Corporate Park)
125 Red Creek Drive
Rochester, NY 14623

Surgical Oncology - Henrietta

Pluta Cancer Center
125 Red Creek Drive
Rochester, NY 14623

About Me


English, Hebrew

Certified Specialties

Clinical Genetics and Genomics (MD) - American Board of Medical Genetics & Genomics

Medical Biochemical Genetics - American Board of Medical Genetics & Genomics

Faculty Appointments

Assistant Professor - Department of Pediatrics, Genetics (SMD)

Assistant Professor - Department of Medicine, Genetics (SMD) - Joint


Residency & Fellowship

Fellowship, Medical Biochemical Genetics, Baylor College of Medicine. 2021 - 2022

Residency, Baylor College of Medicine. 2019 - 2021

Fellowship, Fellow, University of Texas MD Anderson Cancer Center. 2017 - 2019

Fellowship, Research, University of Texas MD Anderson Cancer Center. 2014 - 2017

Fellowship, Hematology, Chaim Sheba Medical Center (Israel). 2011 - 2014

Residency, Internal Medicine, Chaim Sheba Medical Center (Israel). 2006 - 2010


MD | Hadassah Medical School (Israel). 2002


Clinical faculty award, special recognition award metabolic fellow. 2022


Journal Articles

Dual enzyme therapy improves adherence to chemotherapy in a patient with gaucher disease and Ewing sarcoma.

Lucari B, Tallis E, Sutton VR, Porea T

Pediatric hematology and oncology.. 2023 May 40 (4):422-428. Epub 09/20/2022.

Near-Haploid B-Cell Acute Lymphoblastic Leukemia in a Patient with Rubinstein-Taybi Syndrome.

Kurtz KJ, Tallis E, Marcogliese AN, Pulivarthi RH, Potocki L, Stevens AM

Pediatric hematology and oncology.. 2022 November 39 (8):747-754. Epub 03/11/2022.

Untargeted metabolomic profiling in a patient with glycogen storage disease Ib receiving empagliflozin treatment.

Tallis E, Karsenty CL, Grimes AB, Karam LB, Elsea SH, Sutton VR, Rawls-Castillo BL, Liu N, Soler-Alfonso C

JIMD reports.. 2022 July 63 (4):309-315. Epub 05/22/2022.

Evolution of germline TP53 variant classification in children with cancer.

Tallis E, Scollon S, Ritter DI, Plon SE

Cancer genetics.. 2022 June 264-265 :29-32. Epub 03/03/2022.

Novel myeloperoxidase-derived HLA-A2-restricted peptides as therapeutic targets against myeloid leukemia.

Lu S, Tallis E, Ding X, Li D, Cox K, You MJ, St John L, Alatrash G, Ma Q, Molldrem JJ

Cytotherapy.. 2021 September 23 (9):793-798. Epub 06/30/2021.

Patient with mixed-phenotype acute leukemia with rearrangement.

Tallis E, Loghavi S, Jorgensen JL, Wang S, Khoury JD, Bueso-Ramos CB, Jain N, Borthakur G, Pemmaraju N

Leukemia & lymphoma.. 2019 November 60 (11):2829-2831. Epub 04/23/2019.

A novel TCR-like CAR with specificity for PR1/HLA-A2 effectively targets myeloid leukemia in vitro when expressed in human adult peripheral blood and cord blood T cells.

Ma Q, Garber HR, Lu S, He H, Tallis E, Ding X, Sergeeva A, Wood MS, Dotti G, Salvado B, Ruisaard K, Clise-Dwyer K, John LS, Rezvani K, Alatrash G, Shpall EJ, Molldrem JJ

Cytotherapy.. 2016 August 18 (8):985-994. Epub 06/02/2016.

Secondary malignancies after allogeneic stem-cell transplantation in the era of reduced-intensity conditioning; the incidence is not reduced.

Shimoni A, Shem-Tov N, Chetrit A, Volchek Y, Tallis E, Avigdor A, Sadetzki S, Yerushalmi R, Nagler A

Leukemia.. 2013 April 27 (4):829-35. Epub 10/17/2012.

In-vitro activity of cefepime and other broad-spectrum antimicrobials against several groups of gram-negative bacilli and Staphylococcus aureus.

Tallis E, Rudensky B, Attias D, Raveh D, Schlesinger Y, Yinnon AM

Diagnostic microbiology and infectious disease.. 1999 October 35 (2):121-6. Epub 1900 01 01.

Ratings & Comments

At URMC, we believe that patients should be empowered to make the right decisions regarding their personal healthcare. To do so, transparency is critical. URMC partners with Press Ganey, to survey our patients about all aspects of their care experience. We are now putting this pertinent information at your fingertips by displaying star ratings for our providers along with anonymous patient comments on our website. This will help you make better-informed choices about how and with whom you seek care. Click here to learn more about the surveys used to generate this vital information. Learn more about our survey process.